Prostate Cancer Expert Panel Positive on Medivation's (MDVN) Xtandi, UBS Says; Shares Worth Up to $75 in Takeout
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
Medivation (MDVN) Worth $51-$75 in Takeover - Jefferies
March 31, 2016 11:40 AM EDTLooking through the rumors, Jefferies analyst, Biren Amin, values shares of Medivation (NASDAQ: MDVN) in baseline and synergistic scenarios. However, he made no change to his Hold rating or $39 PT.
The baseline scenario values MDVN at $39/share thru a DCF, and included $200M of annual synergies from OpEx. The analyst assumed the acquirers tax rate and calculated a potential... More
Medivation (MDVN) Crosses Above 200 DMA Amid Takeover Speculation
March 31, 2016 10:12 AM EDTMedivation (NASDAQ: MDVN), up early on takeover speculation, just crossed above its 200 Day Moving Average.
Shares are up 17.4% early to $43.89
... MorePre-Open Stock Movers 03/31: (GNCA) (MDVN) (MNOV) Higher; (EGLE) (PRGS) (MOV) Lower (more...)
March 31, 2016 9:31 AM EDTEagle Bulk Shipping, Inc. (Nasdaq: EGLE) 40% LOWER; announced that it has reached an agreement with the Company's lenders and holders of approximately 75% of the Company's outstanding equity for a comprehensive balance-sheet recapitalization. The transaction provides Eagle Bulk with approximately $105 million in incremental liquidity,... More
Medivation (MDVN) Could Be Worth Up to $75/Share in a Takeover - Credit Suisse
March 31, 2016 6:24 AM EDTCredit Suisse analyst Kennen MacKay bumped his price target on Medivation (NASDAQ: MDVN) to $49.00 (from $48.00) following reports the company hired bankers to fend off a takeover. The firm maintained an Outperform rating.
The analyst notes Medivation has become vulnerable to a takeover given the... More
